Incidence of Conjunctivitis and Other Ocular Surface Disorders in Patients With Long-Term Dupilumab Use

Christine E Jo; Jorge R Georgakopoulos; Aaron M Drucker; Vincent Piguet; Jensen Yeung

doi:10.1177/1203475420929920

Incidence of Conjunctivitis and Other Ocular Surface Disorders in Patients With Long-Term Dupilumab Use

J Cutan Med Surg. 2020 Sep/Oct;24(5):527-528. doi: 10.1177/1203475420929920. Epub 2020 May 25.

Authors

Christine E Jo¹, Jorge R Georgakopoulos², Aaron M Drucker^{2

3}, Vincent Piguet^{2

3}, Jensen Yeung^{2

3

4

5}

Affiliations

¹ 6363 Faculty of Medicine, University of Ottawa, ON, Canada.
² 7938 Division of Dermatology, Department of Medicine, University of Toronto, ON, Canada.
³ 798512366 Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, ON, Canada.
⁴ Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
⁵ Probity Medical Research Inc., Waterloo, ON, Canada.

PMID: 32449620
DOI: 10.1177/1203475420929920

No abstract available

Keywords: atopic dermatitis; blepharitis; clinical practice; conjunctivitis; dry eye; dupilumab; keratitis; long-term; ocular surface disorders; red eye.

Publication types

Letter

MeSH terms

Anti-Inflammatory Agents / administration & dosage
Anti-Inflammatory Agents / adverse effects
Anti-Inflammatory Agents / therapeutic use
Antibodies, Monoclonal, Humanized* / administration & dosage
Antibodies, Monoclonal, Humanized* / adverse effects
Antibodies, Monoclonal, Humanized* / therapeutic use
Conjunctivitis / drug therapy
Conjunctivitis / epidemiology*
Dermatitis, Atopic / drug therapy
Humans
Incidence
Retrospective Studies

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal, Humanized
dupilumab